PU
Pulmatrix, Inc.
PULM · NASDAQ
$1.48 -0.66% (-$0.01)
1M -11.46%
Market Cap $4.97M
P/E Ratio -
Div. Yield -
ROE 109.26%
Piotroski F-Score Weak
1/9Valuation
89 /100
Cheap P/B 1.94x
EV/EBITDA N/A
P/S N/A
Growth
0 /100
Declining Book val. growth 50.34%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 109.26%
ROA 123.63%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 4.70x
Debt/Equity 0.00x
Net debt/EBITDA N/A
Stability
31 /100
Unstable Rev. volatility 65.91%
EPS volatility 9.22%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre PULM
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Peter Ludlum
Employees
2
Headquarters
Framingham
Evenimente viitoare
05 NOV.
Earnings
Upcoming earnings report